Bipartisan policies in Congress meant to lower drug costs by targeting middlemen in the pharmaceutical supply chain are likely to run up against a fundamental issue: the three major pharmacy benefit ...
In a conversation hosted by DSN, EmpiRx Health CEO Danny Sanchez and EmpiRx Health President John Ridyard detailed how their mid-market PBM is gaining traction by putting pharmacists at the center of ...
Pharmacy benefit manufacturers complicate the drug pricing system and drive up out-of-pocket costs for patients, according to a new report from Pacific Research Institute. For the report, the Pacific ...
Vertical integration and limited PBM competition can distort formulary placement incentives, enabling rebate-driven list price inflation while obscuring true net costs from employers, pharmacies, and ...
Some employers and health systems in North Carolina are looking to change how they manage prescription drug benefits for their employees. More employers are considering alternative pharmacy benefit ...
The House Committee on Oversight and Government Reform said last week that it’s expanding its investigation into the role of pharmacy benefit managers by seeking information about how they use foreign ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results